1517 related articles for article (PubMed ID: 19046846)
1. Sentinel lymph node biopsy is associated with improved survival compared to level I & II axillary lymph node dissection in node negative breast cancer patients.
Langer I; Guller U; Hsu-Schmitz SF; Ladewig A; Viehl CT; Moch H; Wight E; Harder F; Oertli D; Zuber M
Eur J Surg Oncol; 2009 Aug; 35(8):805-13. PubMed ID: 19046846
[TBL] [Abstract][Full Text] [Related]
2. Axillary lymph node dissection for sentinel lymph node micrometastases may be safely omitted in early-stage breast cancer patients: long-term outcomes of a prospective study.
Langer I; Guller U; Viehl CT; Moch H; Wight E; Harder F; Oertli D; Zuber M
Ann Surg Oncol; 2009 Dec; 16(12):3366-74. PubMed ID: 19760047
[TBL] [Abstract][Full Text] [Related]
3. Is sentinel lymph node biopsy more accurate than axillary dissection for staging nodal involvement in breast cancer patients?
Marrazzo A; Taormina P; Gebbiab V; David M; Riili I; Lo Gerfo D; Casà L; Noto A
Chir Ital; 2007; 59(5):693-9. PubMed ID: 18019642
[TBL] [Abstract][Full Text] [Related]
4. Survival after negative sentinel lymph node biopsy in breast cancer at least equivalent to after negative extensive axillary dissection.
Kuijt GP; van de Poll-Franse LV; Voogd AC; Nieuwenhuijzen GA; Roumen RM
Eur J Surg Oncol; 2007 Sep; 33(7):832-7. PubMed ID: 17197151
[TBL] [Abstract][Full Text] [Related]
5. A Randomized clinical trial on sentinel lymph node biopsy versus axillary lymph node dissection in breast cancer: results of the Sentinella/GIVOM trial.
Zavagno G; De Salvo GL; Scalco G; Bozza F; Barutta L; Del Bianco P; Renier M; Racano C; Carraro P; Nitti D;
Ann Surg; 2008 Feb; 247(2):207-13. PubMed ID: 18216523
[TBL] [Abstract][Full Text] [Related]
6. Erratum to: Axillary recurrence rate following negative sentinel node biopsy for invasive breast cancer: long-term follow-up.
Kiluk JV; Ly QP; Santillan AA; Meade T; Ramos D; Reintgen DS; Dessureault S; Davis M; Shamehdi C; Cox CE
Ann Surg Oncol; 2010 Feb; 17(2):552-7. PubMed ID: 19957043
[TBL] [Abstract][Full Text] [Related]
7. Prognostic implications of isolated tumor cells and micrometastases in sentinel nodes of patients with invasive breast cancer: 10-year analysis of patients enrolled in the prospective East Carolina University/Anne Arundel Medical Center Sentinel Node Multicenter Study.
Reed J; Rosman M; Verbanac KM; Mannie A; Cheng Z; Tafra L
J Am Coll Surg; 2009 Mar; 208(3):333-40. PubMed ID: 19317993
[TBL] [Abstract][Full Text] [Related]
8. Morbidity in breast cancer patients with sentinel node metastases undergoing delayed axillary lymph node dissection (ALND) compared with immediate ALND.
Goyal A; Newcombe RG; Chhabra A; Mansel RE
Ann Surg Oncol; 2008 Jan; 15(1):262-7. PubMed ID: 17879117
[TBL] [Abstract][Full Text] [Related]
9. Completion axillary lymph node dissection not required for regional control in patients with breast cancer who have micrometastases in a sentinel node.
Yegiyants S; Romero LM; Haigh PI; DiFronzo LA
Arch Surg; 2010 Jun; 145(6):564-9. PubMed ID: 20566977
[TBL] [Abstract][Full Text] [Related]
10. Sentinel node biopsy and cytokeratin staining for the accurate staging of 478 breast cancer patients.
Pendas S; Dauway E; Cox CE; Giuliano R; Ku NN; Schreiber RH; Reintgen DS
Am Surg; 1999 Jun; 65(6):500-5; discussion 505-6. PubMed ID: 10366202
[TBL] [Abstract][Full Text] [Related]
11. Survival outcomes in node-negative breast cancer patients evaluated with complete axillary node dissection versus sentinel lymph node biopsy.
Cox C; White L; Allred N; Meyers M; Dickson D; Dupont E; Cantor A; Ly Q; Dessureault S; King J; Nicosia S; Vrcel V; Diaz N
Ann Surg Oncol; 2006 May; 13(5):708-11. PubMed ID: 16538416
[TBL] [Abstract][Full Text] [Related]
12. Avoidance of axillary lymph node dissection in selected patients with node-positive breast cancer.
Noguchi M
Eur J Surg Oncol; 2008 Feb; 34(2):129-34. PubMed ID: 17498911
[TBL] [Abstract][Full Text] [Related]
13. Omitting axillary lymph node dissection in sentinel node negative breast cancer patients is safe: a long term follow-up analysis.
Torrenga H; Fabry H; van der Sijp JR; van Diest PJ; Pijpers R; Meijer S
J Surg Oncol; 2004 Oct; 88(1):4-7; discussion 7-8. PubMed ID: 15384064
[TBL] [Abstract][Full Text] [Related]
14. Axillary recurrences after negative sentinel lymph node biopsy under local anaesthesia for breast cancer: a follow-up study after 5 years.
Groetelaers RP; van Berlo CL; Nijhuis PH; Schapers RF; Gerritsen HA
Eur J Surg Oncol; 2009 Feb; 35(2):159-63. PubMed ID: 18789841
[TBL] [Abstract][Full Text] [Related]
15. Comparison of sentinel lymph node biopsy alone and completion axillary lymph node dissection for node-positive breast cancer.
Bilimoria KY; Bentrem DJ; Hansen NM; Bethke KP; Rademaker AW; Ko CY; Winchester DP; Winchester DJ
J Clin Oncol; 2009 Jun; 27(18):2946-53. PubMed ID: 19364968
[TBL] [Abstract][Full Text] [Related]
16. Long-term morbidity of patients with early breast cancer after sentinel lymph node biopsy compared to axillary lymph node dissection.
Schulze T; Mucke J; Markwardt J; Schlag PM; Bembenek A
J Surg Oncol; 2006 Feb; 93(2):109-19. PubMed ID: 16425290
[TBL] [Abstract][Full Text] [Related]
17. The effect of sentinel node tumor burden on non-sentinel node status and recurrence rates in breast cancer.
Fan YG; Tan YY; Wu CT; Treseler P; Lu Y; Chan CW; Hwang S; Ewing C; Esserman L; Morita E; Leong SP
Ann Surg Oncol; 2005 Sep; 12(9):705-11. PubMed ID: 16079953
[TBL] [Abstract][Full Text] [Related]
18. Minimal axillary lymph node involvement in breast cancer has different prognostic implications according to the staging procedure.
Montagna E; Viale G; Rotmensz N; Maisonneuve P; Galimberti V; Luini A; Intra M; Veronesi P; Mazzarol G; Pruneri G; Renne G; Torrisi R; Cardillo A; Cancello G; Goldhirsch A; Colleoni M
Breast Cancer Res Treat; 2009 Nov; 118(2):385-94. PubMed ID: 19562480
[TBL] [Abstract][Full Text] [Related]
19. A prospective evaluation of positron emission tomography scanning, sentinel lymph node biopsy, and standard axillary dissection for axillary staging in patients with early stage breast cancer.
Lovrics PJ; Chen V; Coates G; Cornacchi SD; Goldsmith CH; Law C; Levine MN; Sanders K; Tandan VR
Ann Surg Oncol; 2004 Sep; 11(9):846-53. PubMed ID: 15313737
[TBL] [Abstract][Full Text] [Related]
20. Optimal use of sentinel lymph node biopsy versus axillary lymph node dissection in patients with breast carcinoma: a decision analysis.
Wong SL; Abell TD; Chao C; Edwards MJ; McMasters KM
Cancer; 2002 Aug; 95(3):478-87. PubMed ID: 12209739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]